Alkami Technology stock tumbles after ending strategic review
Alkami Technology shares fell after the company ended a strategic review without announcing a transaction. The decision leaves investors focused on Alkami’s standalone path after takeover expectations had entered the stock’s setup.
Alkami Technology ended its strategic review, a decision that was followed by a sharp decline in its shares. The company did not announce a transaction alongside the review’s conclusion.
The review had placed a potential sale or other strategic outcome alongside Alkami’s existing operating business. Its conclusion shifts the near-term story back toward execution as a standalone financial-technology company.
Alkami’s business generated $443.6M of revenue in fiscal 2025, up 32.9% year over year. The company reported a 57.8% gross margin, a -10.7% net margin and $-0.46 diluted EPS for that period.
The immediate uncertainty is how the market will value Alkami without a strategic transaction premium or a disclosed deal process. The next operating results and management commentary should show whether growth and progress toward profitability can replace that source of potential value.
Alkami Technology (ALKT) ended its strategic review without announcing a transaction, sending shares lower.
The failed transaction path removes a potential source of near-term value and returns the stock’s setup to Alkami’s operating trajectory. Fiscal 2025 revenue grew 32.9% to $443.6M, but the company remained loss-making with a -10.7% net margin and $-0.46 diluted EPS, leaving the next results and management commentary to establish whether growth is translating into improving profitability.
A subsequent strategic transaction or materially better profitability outlook would undercut the standalone read.
CoverageSource: Investing.com · Published here WED, SEP 23 · 9:05 AM ET · the only report in this recordHow this is decided →
STOCK PHOTO · SUMITOMO TANEarlier context and later coverage are dated relative to this report. Automatically linked reports may cover a broader event.
No later reports linked yet.
Follow this story to find new evidence in your Following desk.
Alkami’s $443.6M of fiscal 2025 revenue grew 32.9% year over year, giving the standalone business a substantial growth record despite the review ending.
The strategic review ended without a transaction while fiscal 2025 still showed a -10.7% net margin and $-0.46 diluted EPS.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →